HHMI
OVV icon

Howard Hughes Medical Institute’s Ovintiv OVV Stock Holding History

Howard Hughes Medical Institute’s Portfolio OVV Stock Details OVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-26,681
Closed -$1.17M – 96
2017
Q2 		$1.17M Sell
26,681
-2,163
-7% -$112K 0.21% 65
2017
Q1 		$1.69M Buy
28,844
+78
+0.3% +$4.67K 0.31% 63
2016
Q4 		$1.69M Buy
28,766
+4,725
+20% +$269K 0.39% 56
2016
Q3 		$1.26M Buy
24,041
+213
+0.9% +$9.56K 0.32% 61
2016
Q2 		$928K Buy
23,828
+22,748
+2,106% +$833K 0.31% 69
2016
Q1 		$33K Buy
+1,080
New +$24.9K 0.01% 148

Other funds holding OVV

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Steadfast Capital Management New York $2.92B AUM 26.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Howard Hughes Medical Institute's OVV Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Ovintiv (OVV) in Q3 2017, closing a stake of 26,681 shares — an estimated $1.17M sold.

Howard Hughes Medical Institute first reported a position in OVV in Q1 2016 and held it in 6 quarters. The position peaked at $1.69M in Q1 2017. 338 funds tracked by Wall St. Rank hold OVV as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Ovintiv position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 26,681 Ovintiv shares in Q3 2017, an estimated $1.17M.
  • Howard Hughes Medical Institute first reported a position in Ovintiv in Q1 2016 and held it in 6 quarters.
  • Howard Hughes Medical Institute's Ovintiv position peaked at $1.69M in Q1 2017.
  • 338 funds tracked by Wall St. Rank held Ovintiv as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.